About CryoSave
CryoSave is a company based in Pretoria (South Africa) founded in 2001. CryoSave offers products and services including Stem Cell Banking. CryoSave operates in a competitive market with competitors including StemCyte, Cryo-Cell, China Cord Blood, China Cord Blood Corporation and BioLife Plasma Services, among others.
- Headquarter Pretoria, South Africa
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cryo-Save (India) Private Limited
- Date of Incorporation 29 Feb, 2008
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$2.72 M (USD)-15.73as on Mar 31, 2017
-
Net Profit
-$724.03 K (USD)-808.71as on Mar 31, 2017
-
EBITDA
-$481.47 K (USD)-314.28as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CryoSave
CryoSave offers a comprehensive portfolio of products and services, including Stem Cell Banking.
Collects and stores newborn stem cells for future treatments.
People of CryoSave
Unlock access to complete
Unlock access to complete
Funding Insights of CryoSave
Detailed funding history for CryoSave
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CryoSave
Investment portfolio details for CryoSave
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CryoSave
Detailed financials for CryoSave
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cryosave Comparisons
Peer comparison for CryoSave
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CryoSave
CryoSave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as StemCyte, Cryo-Cell, China Cord Blood, China Cord Blood Corporation and BioLife Plasma Services, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Umbilical cord blood stem cell transplantation and therapeutic products company
|
|
| Locked | Locked | Locked |
Cord blood and tissue stem cells are stored for preservation.
|
|
| Locked | Locked | Locked |
Biobanking services for umbilical cord blood stem cells are provided.
|
|
| Locked | Locked | Locked |
Umbilical cord blood stem cell banking services are provided.
|
|
| Locked | Locked | Locked |
BioLife Plasma Services collects high-quality plasma and processes it into lifesaving therapies.
|
|
| Locked | Locked | Locked |
Stem cell biobanking and manufacturing from children's teeth are provided.
|
Detailed competitors of CryoSave
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cryosave
Complete news archive for CryoSave
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CryoSave
CryoSave was founded in 2001.
CryoSave is headquartered in Pretoria, South Africa. It is registered at Pretoria, Gauteng, South Africa.
Donald Gilroy is the current CEO of CryoSave.
Annual revenue of CryoSave is $2.72M as on Mar 31, 2017.
CryoSave SA was established in 2001 in Pretoria, South Africa, as a private stem cell bank. Umbilical cord blood is collected and stored by the company for potential regenerative applications in repairing and protecting the body. Operations focus on secure, long-term preservation in specialized facilities, serving families across the country in the biotechnology sector. Leadership is provided by co-CEOs Donald Gilroy and Lizel Channon.
CryoSave's top competitors include StemCyte, Cryo-Cell and Forever Labs.
CryoSave offers Stem Cell Banking.